Annual report
6951.TEDINET S100YIDD
Period2025-04-01 → 2026-03-31
Filed2026-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥179.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥196.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥174.3bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥162.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥138.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥26.0bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥35.5bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥28.6bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥34.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥30.0bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.5bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.3bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥29.5bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥25.0bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥22.1bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥18.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.7bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥17.8bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.3bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥22.1bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥18.7bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥242.0bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥222.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥230.2bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥199.3bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥189.6bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥97.1bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥85.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥144.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥136.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥125.5bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥101.9bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥85.9bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥38.9bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥36.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥37.3bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.6bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.0bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥42.4bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥16.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥15.3bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥22.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥13.8bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥855m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥648m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥17.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥798m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥5.5bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥432.58 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥365.55 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥424.92 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥349.34 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥246.78 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,975.26 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,672.19 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,457.01 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,995.55 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,684.08 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 59.9% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.5% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 15.7% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.0% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.9% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,731 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 3,604 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 3,435 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 3,351 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 3,291 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥147.1bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥165.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥146.1bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥135.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥117.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥21.9bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥32.3bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥26.3bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥33.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥29.4bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥22.9bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.4bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥27.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥23.6bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥21.0bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥18.2bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥21.2bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥17.5bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.1bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥201.4bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥186.5bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥197.2bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥169.3bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥159.8bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥74.0bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥62.2bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥127.4bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥124.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥113.5bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥93.7bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥79.0bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥16.4bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥16.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥410.24 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥356.61 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥414.5 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥343.37 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.8 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥132 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥106 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥102 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥66 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,616.78 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,430.26 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,220.9 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,836 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,548.9 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 63.3% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.6% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.5% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.4% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.7% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.3% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.4% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.3% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.3% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 51,532,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,532,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,532,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,532,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,532,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,313 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 2,315 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,277 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 2,259 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 2,092 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥1.6bn |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥299m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥49.9bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥6.5bn |
| Industrial Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥2.8bn |
| Industrial Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Industrial Equipmentreportable segment | employees | at 2026-03-31 | 659 pure |
| Industrial Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥48.1bn |
| Industrial Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥48.1bn |
| Industrial Equipmentreportable segment | segment assets | at 2026-03-31 | ¥51.3bn |
| Industrial Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥19.4bn |
| Medical Equipmentreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥335m |
| Medical Equipmentreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥318m |
| Medical Equipmentreportable segment | employees | at 2026-03-31 | 290 pure |
| Medical Equipmentreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥14.9bn |
| Medical Equipmentreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥14.9bn |
| Medical Equipmentreportable segment | segment assets | at 2026-03-31 | ¥18.0bn |
| Medical Equipmentreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥64m |
| Scientific And Measurement Instrumentsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥15.5bn |
| Scientific And Measurement Instrumentsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥3.3bn |
| Scientific And Measurement Instrumentsreportable segment | employees | at 2026-03-31 | 2397 pure |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥116.3bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥116.3bn |
| Scientific And Measurement Instrumentsreportable segment | segment assets | at 2026-03-31 | ¥122.8bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥13.1bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥18.6bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥5.1bn |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥179.4bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥179.4bn |
| —segment total | segment assets | at 2026-03-31 | ¥192.2bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥32.5bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥337m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥47.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥6.5bn |
| Industrial Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Industrial Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Industrial Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥56.5bn |
| Industrial Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥56.5bn |
| Industrial Equipmentreportable segment | segment assets | at 2025-03-31 | ¥51.4bn |
| Industrial Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥26.3bn |
| Medical Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥235m |
| Medical Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥325m |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥15.4bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥15.4bn |
| Medical Equipmentreportable segment | segment assets | at 2025-03-31 | ¥13.9bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥662m |
| Scientific And Measurement Instrumentsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥3.8bn |
| Scientific And Measurement Instrumentsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥3.0bn |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥124.8bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥124.8bn |
| Scientific And Measurement Instrumentsreportable segment | segment assets | at 2025-03-31 | ¥109.6bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥15.0bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥5.8bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥4.6bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥196.7bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥196.7bn |
| —segment total | segment assets | at 2025-03-31 | ¥174.8bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥42.0bn |
| Industrial Equipmentreportable segment | employees | at 2026-03-31 | 455 pure |
| Medical Equipmentreportable segment | employees | at 2026-03-31 | 276 pure |
| Scientific And Measurement Instrumentsreportable segment | employees | at 2026-03-31 | 1389 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,864
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0446 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 2724000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 53.00 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 3889000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 79.00 | |
| Number of male directors and other officers | FilingDateInstant | 11 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.154 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000OoiIzumiMember | 10100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000YaguchiKatsumotoMember | 6100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000KaneyamaToshikatsuMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000KobayashiAkihiroMember | 6500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000KanayamaToshihikoMember | 2900 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000KannoRyujiMember | 1500 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000TerashimaKaoruMember | 700 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000YomoYukariMember | 800 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000NakaoAkihiroMember | 1100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000FukuyamaKouichiMember | 2100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000TakahashiMitsuruMember | 7100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000MinatoAkihikoMember | 400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01905-000OshimiYukakoMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 40300 | |
| Number of male directors and other officers proposal | FilingDateInstant | 8 | |
| Number of female directors and other officers proposal | FilingDateInstant | 3 | |
| Ratio of female directors and other officers proposal | FilingDateInstant | 0.273 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000OoiIzumiMember | 10100 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000YaguchiKatsumotoMember | 6100 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000KanayamaToshihikoMember | 2900 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000KannoRyujiMember | 1500 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000TerashimaKaoruMember | 700 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000YomoYukariMember | 800 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000NakaoAkihiroMember | 1100 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000FukuyamaKouichiMember | 2100 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000TakahashiMitsuruMember | 7100 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000OshimiYukakoMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E01905-000HirokawaAsamiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant | 32400 | |
| Audit fees reporting company | Prior1YearDuration | 70000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 78000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | 5000000 | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 70000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 78000000 | JPY |
| Non audit fees total | CurrentYearDuration | 5000000 | JPY |
| Audit fees reporting company network firms | Prior1YearDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |